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Abstract 
Background: There is inconclusive evidence on the association between ambient air pollution and pulmonary 
tuberculosis-related hospital admission and mortality. This review aims to assess if and to what extent, selected air 
pollutants are associated to pulmonary tuberculosis (PTB) incidence, hospital admissions and mortality.
Methods: This will be a systematic review and meta-analysis of studies published in English between January 1st, 
1946 and October 31st, 2020, quantitatively assessing the association between air pollutants and PTB incidence, 
hospital admissions and mortality. A comprehensive search strategy will be used to search the databases: Medline, 
Embase, Scopus and The Cochrane Library. Retrieved studies will be screened based on the set eligibility criteria and 
data will be extracted from eligible studies. Extracted data will be analysed on STATA version 14.0 software. Studies 
included will be assessed for their quality using the respective Study Quality Assessment Tools of the National Health 
Institute. The quality of the evidence on the study outcomes will be graded using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) approach. The risk of bias will be assessed using Cochrane’s Risk of 
Bias In Non-randomized Studies-of Interventions (ROBINS-I) tool. Study characteristics, socio-demographic and clinical 
characteristics across eligible studies will be summarised and presented. Pooled estimates of the measures of associa-
tion between air pollutants and PTB incidence, hospital admission and mortality will be obtained through random-
effect meta-analyses models and the respective  I2 test statistics will be reported. Meta-regression analyses will be 
done in case of significant between-study heterogeneity.
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Background
Significant progress has been made worldwide in the 
control of the tuberculosis (TB) epidemic over the past 
two and a half decades [1]. Nevertheless TB still remains 
a global health emergency, being one of the top 10 causes 
of death worldwide and the leading cause of death from a 
single infectious agent [2]. In 2018, up to 10 million new 
cases of tuberculosis and 1.5 million tuberculosis-related 
deaths were reported [2]. Despite this significant progress 
in TB control over the years, much still needs to be done 
to end the TB epidemic by the next decade. At the pre-
sent rate of 2% annual decrease in tuberculosis incidence 
worldwide, there are reasonable concerns that the World 
Health Organisation’s (WHO) sustainable development 
goal (SDG) to end the TB epidemic by 2030 [3] will not be 
attained globally, most especially with the growing resist-
ance to Rifampicin and the emergence of drug-resistant 
TB which currently constitutes a public health crisis 
[2, 4]. Of more pressing concern is the End TB strategy 
2020 milestones of a 35% reduction in TB deaths and a 
20% reduction in TB incidence rate [2] which are unlikely 
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a significant economic burden to affected households, 
despite being easily treatable and preventable when diag-
nosed and managed in an appropriate and timely man-
ner. The commonest predisposing factors to TB infection 
are other health risks such as smoking, diabetes, human 
immunodeficiency virus (HIV) and social determinants 
of health such as poverty, malnutrition, poor ventilation 
and over-crowding among others [2, 5]. This therefore 
means that attaining the WHO’s SDG target of ending 
the TB epidemic worldwide by 2030 [2] requires a multi-
faceted and multi-sectorial approach to TB prevention, 
case identification, management and control of its health 
and social determinants [5, 6].
Addressing all known TB risk factors from all perspec-
tives is therefore essential in tackling the TB epidemic by 
the end of the decade. With the increasing global urbani-
sation, transportation-related emissions and increased 
energy consumption, air pollution has become a global 
problem and will be an important factor to deal with 
in the fight against TB. This is because there are grow-
ing concerns of ambient air pollution being linked to 
increased TB-related hospital admissions and deaths [7, 
8]. There is a well-known association between different 
air pollutants and cardio-respiratory diseases in both 
adults and children [9–11]. Several large reports have 
linked air pollutants such as particulate matter (PM), 
ozone  (O3) and nitrogen dioxide  (NO2) among others to 
both the development and exacerbation of airway dis-
ease including asthma and COPD [12–14] and other res-
piratory conditions [15, 16]. Air pollutants when inhaled, 
suppress the natural defence barriers of the respiratory 
tract by inhibiting macrophage action and muco-ciliary 
clearance, and initiating a chronic inflammatory response 
through the generation of inflammatory mediators and 
free-radicals, thereby increasing susceptibility to infec-
tions and sensitivity to allergens [12, 17, 18]. PTB has 
been previously shown to be associated with indoor 
pollution from activities such as smoking, biomass fuel 
burning [19–21]. Despite this background knowledge of 
the association between indoor air pollution and PTB 
risk, not much has been reported about the contribution 
of ambient air pollution to the risk of PTB development 
or exacerbation. Rajaei et  al. using geographical infor-
mation systems, showed a possible association between 
long-term exposure to  PM2.5 and CO and TB develop-
ment but not with  SO2, NO, and  PM10 [7]. Another study 
reported a potential link between  PM2.5,  PM10,  SO2,  NO2 
and active PTB [8]. On the other hand Hwang et al. found 
no link between  PM10, CO,  NO2,  O3 and PTB, but rather 
with  SO2 [22]. Variations in study settings, study designs 
and study populations could potentially account for 
these contrasting findings across studies. The systematic 
review conducted by Popovic et al. in 2018 which is the 
only published synthesis of studies on the link between 
ambient pollution and PTB to date showed mixed results 
[23]. This review reported that  PM2.5 was the air pollut-
ant most frequently associated with PTB. This review 
also found no evidence of association between CO and 
 O3 and active PTB and limited evidence of associations 
between  PM10,  SO2, and  NO2 and active PTB [23]. The 
systematic review, however, did not quantitatively assess 
to what extent these air pollutants might be associated 
to active PTB. Also, several other studies which provide 
more evidence on this topic were published after the sys-
tematic review. The uncertainty of which air pollutants 
could be linked to PTB and to what extent, is therefore 
amenable to further exploration.
This review will enable us to ascertain if available evi-
dence suggests ambient air pollution is associated to PTB 
and to what extent these air pollutants are linked to PTB 
incidence, tuberculosis-related hospital admissions and 
deaths, by systematically reviewing and quantitatively 
synthesising published evidence on this topic. This is 
particularly relevant as identifying potentially modifiable 
environmental determinants of PTB and the socio-demo-
graphic and clinical characteristics of at-risk population 
groups would greatly help to inform policy and decision 
making with regards to targeted control measures and 
prevention strategies, in line with WHO’s SDG goal to 
end the TB epidemic in 2030. [2, 3].
Objectives of the review
This review has as primary review questions: Is ambient 
air pollution associated with PTB incidence, mortality 
and hospital admissions? And if so, what air pollutants 
are involved? The specific objectives of the review are:
1. To determine if there is an association between air 
pollution and PTB incidence, mortality and hospital 
admissions
2. To determine to what extent selected air pollutants 
 (PM2.5,  PM10,  NO2,  SO2, CO,  O3) are associated to 
PTB incidence, mortality and/or hospital admissions
Methods
The study has been registered with the international 
prospective register of systematic reviews (PROSPERO 
registration number: CRD42020165888). The RepOrting 
standards for Systematic Evidence Syntheses (ROSES) 
for systematic review protocols [24] were used to report 
this protocol as presented in Additional file 1. Likewise, 
the completed systematic review and meta-analysis will 
be reported in accordance with the ROSES for systematic 
review reports. Amendments made to this protocol will 
be documented and justified accordingly.
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Searching for articles
This will be a systematic review of studies that quantita-
tively test for any association between ambient air pol-
lution and PTB including drug-resistant TB. The search 
strategy to be used is presented in Table  1. The search 
will be run by two independent reviewers (CAD and 
BMK). The medical subject headings (MeSH) searches 
of the keywords; air pollution; tuberculosis, incidence, 
mortality, hospital admission and hospitalisation will 
be combined with the respective free-text searches of 
these keywords and more keywords using the Boolean 
operator ‘OR’. The respective outputs from these initial 
searches will then be combined using the Boolean opera-
tor ‘AND’ to obtain the definitive search results. The 
databases to be searched will include Medline, Embase, 
Scopus and The Cochrane Library and all searches will be 
conducted in English. The reference list of eligible articles 
will be searched, but no other specialist searches will be 
done including grey literature search, stakeholder con-
tacts, organisational website searches or public calls for 
literature.
Article screening and eligibility criteria
Screening process
Articles returned by the search will be saved on Zotero 
Version 5.0 reference management software from where 
duplicates of articles will be removed by the princi-
pal investigator (CAD). The titles and abstracts of the 
remaining articles will then be screened by two inde-
pendent reviewers (CAD and BMK) to identify and 
exclude studies which are out of scope and unrelated 
to the study objectives. For consistency checks, the two 
reviewers will then check with each other the number of 
records they each retained for full text review to make 
sure their numbers match and any discrepancies will be 
reviewed and addressed by both reviewers. The review-
ers will then review the full texts of the retained articles 
for their eligibility based on the study selection criteria. 
Thereafter, the two reviewers will compare their final 
eligible list of studies to ensure concordance in their 
selection. In case of any mismatch in the eligible stud-
ies identified by both reviewers, these two reviewers will 
again review the discrepancy to agree on a final list. Any 
disagreement between the two reviewers at any point 
during the article screening process will be subject to 
arbitration by a third reviewer (AH). More studies will be 
assessed for eligibility by reviewing the reference list of 
eligible studies. A list of studies excluded following full 
text review will be made with the respective reasons for 
their exclusion.
Eligibility criteria
The following studies will be included:
1. Studies published in English between January 1st, 
1946 and the date of the search
2. Population: Studies focused on patients of all ages 
with confirmed PTB including drug-resistant TB
3. Exposure: Studies that report on any of the air pol-
lutants; carbon monoxide (CO), nitrogen dioxide 
 (NO2), sulphur dioxide  (SO2), ozone  (O3), particulate 
matter ≤ 2.5 micrometres  (PM2.5) and/or particulate 
matter ≤ 10 micrometres  (PM10)
4. Comparator: more or less air pollution
5. Outcomes: Studies that report risk of TB incidence, 
hospital admission and/or mortality from PTB or 
some other measure of effect from which the risk or 
odds ratios can be calculated
6. Study design/Other: Cross-sectional, case–control, 
cohorts, case-crossover and time-series studies that 
report on the association between ambient air pollu-
tion and PTB.
The following studies will be excluded
1. Population: Studies that report on patients of all ages 
with respiratory diseases other than PTB and studies 
that report on extrapulmonary TB rather than PTB
Table 1 Ovid Medline and  Embase Search Strategy for  study on  the  association between  ambient air pollution 
and pulmonary tuberculosis
MeSH Medical Subject Headings
Search # Search words
1 Air pollution (MeSH terms) OR air pollution OR ambient air pollution OR outdoor air pollution OR air pollutants OR environmental pollutants 
Carbon monoxide OR CO OR Nitrogen dioxide OR  NO2 OR Sulphur dioxide OR  SO2 OR Ozone OR  O3 OR Particulate matter OR  PM10
2 Tuberculosis (MeSH) OR tuberculosis OR pulmonary tuberculosis OR TB OR mycobacterial infection OR mycobacterium OR drug-resistant 
tuberculosis OR multidrug-resistant tuberculosis OR MDR-TB OR XDR-TB
3 Incidence (MeSH) OR hospital admission (MeSH) OR hospitalisation (MeSH) OR mortality (MeSH) OR incidence OR admission OR mortality 
OR death
4 #1 AND #2 AND #3
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2. Exposure: Studies reporting exclusively on indoor air 
pollution with no assessment of ambient or outdoor 
air pollution
3. Outcomes: Studies reporting outcomes related to 
PTB in combination with other respiratory diseases. 
Studies from which data on measures of effect/asso-
ciation such as relative risk, risk ratios and odds 
ratios are inadequately reported
4. Study design/Other: Conference abstracts, editorials, 
letters, opinion papers, same studies published in dif-
ferent journals with the same or a different title
For prospective studies with multiple publication of 
their results over time, only the most recent publication 
that provides adequate quantitative data will be consid-
ered for the meta-analysis. Data from single-pollutant 
models will be given preference over data from multi-
pollutant models for studies that provide both. Data 
from multi-pollutant models will be considered if there is 
consistency in the air-pollutants considered in the multi-
pollutant models across two or more studies. Adjusted 
measures of effect/association will be given preference 
over crude measures when both are reported.
Study validity assessment
Assessment of study quality and risk of bias will be done 
by two independent reviewers (CAD and BMK). Par-
ticular attention will be paid to; the study designs; the 
availability of clearly reported measures of effect/asso-
ciation on the outcomes of interest; and the reporting 
and control of confounders. The quality of studies will 
be graded as poor, fair, good using appropriate Study 
Quality Assessment Tools of the National Health Insti-
tute/National Heart, Lung and Blood Institute (NHI/
NHLBI) [25]. The criteria used by the quality assessment 
tool assess the method of randomisation of the partici-
pants to the study, treatment concealment, blinding of 
participants and investigators, the similar across groups 
at baseline, the drop-out rate, the extent of adherence of 
participants to the intervention protocol and the reported 
sample sizes. The study quality will be considered during 
study synthesis to assess its effect on the overall results. 
The risk of bias will be assessed using Cochrane’s Risk Of 
Bias In Non-randomized Studies-of Interventions (ROB-
INS-I) tool [27].
The quality of the cumulative evidence on the out-
come measures (hospital admissions and mortality) will 
be assessed and graded as high, moderate, low and very 
low, using the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) approach on the 
bases of the study limitations, inconsistencies, indirect-
ness, imprecision and publication bias [26].
Data coding and extraction strategy
Meta-data (first author and publication year), and data on 
study methods and outcomes of interest will be extracted 
by the principal investigator (CAD) from the eligible 
studies, including: Study location (region, country and 
city or province or county), study design, socio-demo-
graphic and clinical characteristics of study participants, 
study duration, data on pollutants of interest (CO,  NO2, 
 SO2,  O3,  PM2.5 and  PM10), the average ambient tempera-
ture over the study period, incidence of PTB during study 
duration, measures of effect/association (risk ratios, odds 
ratios, hazard ratio, relative risk, percentage change, and 
their respective confidence intervals) of unit increments 
(in µg/m3) in the various air pollutant concentrations on 
the incidence, mortality and hospital admissions due to 
PTB and confounders reported by the respective stud-
ies. Air pollutant data collected will include the method 
of measurement of air pollutants’ concentration and the 
median and/or mean pollutant concentrations during 
the study period. Air pollutant concentration units of 
measurement considered will be µg/m3, parts per mil-
lion (ppm), and parts per billion (ppb). Where different 
units of air pollutant concentrations are reported, appro-
priate conversions will be done according to standards 
to ensure consistency. Where studies provide sufficient 
data, the appropriate measures of effect and associa-
tion will be calculated accordingly and added into the 
data extraction sheet. Potential effect modifiers and con-
founder such as study location, temperature and season-
ality will also be recorded. Relevant missing and unclear 
data will be sought by directly contacting the authors of 
the respective studies by their provided emails and will 
be added to the data extraction sheet once provided. All 
data extracted and the coding will be double-checked for 
errors by a second investigator (BMK) and discrepan-
cies in entries will be settled by discussions between both 
investigators. Disagreements between the investigators 
will be subject to arbitration by a third investigator (AH). 
Data will be extracted unto a Microsoft excel office 365 
sheet and exported to STATA version 14 statistical soft-
ware for analysis. Extracted data will be made available as 
Additional file 1.
Data synthesis and presentation
A narrative synthesis of the study characteristics (study 
location, study design, study duration and total partici-
pants) will be presented and this will be complemented 
by figures and tables summarising descriptive statistics 
such as a means, and frequencies of the socio-demo-
graphic and clinical characteristics of the participants 
in the various studies. Meta-analyses will be done using 
random-effects models to account for the possibility of 
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between-study heterogeneity. Studies with incomplete or 
missing data and studies from which appropriate meas-
ures of effect/association (risk ratios, odds ratio, hazard 
ratios, relative risk and percentage change) cannot be 
derived, will not be included in the meta-analysis. The 
first and second study objectives will be addressed by 
deriving random-effect pooled estimates for the meas-
ures of association between the various air pollutants and 
the outcomes of interests (hospital admission and mor-
tality) gathered from the various studies. Heterogeneity 
between studies will be assessed using the Cochrane’s Q 
test and the  I2 test statistic reported as a measure of the 
extent of this heterogeneity. Meta-analysis findings will 
be summarised in tables and forest plots. Studies assess-
ing exposure to air pollutants at different levels (individ-
ual versus population-level) will be analysed separately. 
Likewise, studies with different methods of measuring 
air pollutant concentrations will be analysed separately. 
If data collected allows for the possibility of combining 
the meta-analysis for studies that used different meth-
ods of measurement of air pollutant concentrations, 
then sub-groups analyses according to the various meth-
ods of measurement of air pollutant concentration in 
the atmosphere will also be done to assess their impact 
on the overall results. Meta-regression analyses will also 
be done to assess for between-study heterogeneity and 
explore other parameters that could affect PTB distribu-
tion such as study year, duration and location. Graphical 
and Statistical assessments of publication bias and small 
study effect will be conducted by ways of funnel plots and 
Harbord’s and Peter’s statistical tests respectively [28]. 
Meta-regression analyses will be done to explore poten-
tial factors that could account for between-study hetero-
geneity, if any.
The RepOrting standards for Systematic Evidence Syn-
theses (ROSES) for systematic review protocols [28] were 
used to report this protocol as presented in Additional 
file 1. Likewise, the systematic review and meta-analysis 
proper once completed will be reported in accordance 
with the ROSES for systematic review reports. Amend-
ments made to this protocol will be documented and 
justified accordingly. The findings of this study will be 
published in a peer-reviewed journal and made widely 
available to the respective health institutions and health 
care providers and patients.
We envisage some limitations to this review. The review 
may overestimate the effect of the various air pollutants 
and their contribution to the development of PTB. This 
is because the nature of clinical presentation of the cases 
admitted to hospital and the synergistic effect of several 
pollutants makes it clinically impracticable to quantify 
with precision the impact of the individual air pollutants. 
Preferentially selecting data from single-pollutant models 
and including multi-pollutant models including the 
same air pollutants will help minimise this confounding 
effect. Also, this study does not take into consideration 
the contribution of household/indoor air pollution to the 
increased risk of hospital admission and mortality from 
PTB, as well as the contribution of other comorbidities or 
health conditions. Finally, as with all ecological studies, 
this study will be limited by the ecological fallacy which 
means individual level exposures to air pollutants can-
not accurately be predicted from measurements at city 
or country level and consequently, associations we may 
observe after aggregating data from cities or countries 
may not necessarily hold at the individual level in these 
populations.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1375 0-020-00213 -9.
Additional file 1. The RepOrting standards for Systematic Evidence 
Syntheses (ROSES) for systematic review protocols for the systematic 





CAD and AH conceived and designed the experiments. CAD produced the 
manuscript. BMK and AH reviewed the manuscript. All authors read and 
approved the final manuscript.
Funding
None.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
This systematic review and meta-analysis does not require ethical approval as 
it entails a synthesis of data collected from several primary studies. No primary 




The authors declare that they have no competing interests.
Author details
1 Health and Human Development (2HD) Research Network, Douala, Came-
roon. 2 Centre for Environmental Health and Sustainability, University of Leices-
ter, Leicester, UK. 3 Infectious Diseases Unit, University Hospitals of Leicester 
NHS Trust, Leicester, UK. 4 Department of Clinical Sciences, Liverpool School 
of Tropical Medicine, Liverpool, UK. 
Received: 25 August 2020   Accepted: 17 November 2020
Page 6 of 6Dimala et al. Environ Evid            (2020) 9:29 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
References
 1. GBD Tuberculosis Collaborators. Global, regional, and national burden of 
tuberculosis, 1990–2016: results from the Global Burden of Diseases, Inju-
ries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018;18(12):1329–49.
 2. World Health Organization. Global Tuberculosis Report 2019. Geneva: 
World Health Organization; 2019.
 3. United Nations. Sustainable Development Goals. Goal 3: Ensure healthy 
lives and promote well-being for all at all ages. https ://www.un.org/susta 
inabl edeve lopme nt/healt h/. Accessed 17 Jan 2020.
 4. United Nations General Assembly. Resolution 73/3: Political declaration 
of the high-level meeting of the General Assembly on the fight against 
tuberculosis. United Nations; 2018. https ://www.un.org/en/ga/searc h/
view_doc.asp?symbo l=A/RES/73/3.
 5. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JDH. The 
social determinants of tuberculosis: from evidence to action. Am J Public 
Health. 2011;101(4):654–62.
 6. Grobusch MP, Kapata N. Global burden of tuberculosis: where we are and 
what to do. Lancet Infect Dis. 2018;18(12):1291–3.
 7. Rajaei E, Hadadi M, Madadi M, Aghajani J, Ahmad MM, Farnia P, et al. 
Outdoor air pollution affects tuberculosis development based on geo-
graphical information system modeling. Biomed Biotechnol Res J BBRJ. 
2018;2(1):39.
 8. Li Z, Mao X, Liu Q, Song H, Ji Y, Xu D, et al. Long-term effect of exposure 
to ambient air pollution on the risk of active tuberculosis. Int J Infect Dis. 
2019;1(87):177–84.
 9. Requia WJ, Adams MD, Arain A, Papatheodorou S, Koutrakis P, Mahmoud 
M. Global association of air pollution and cardiorespiratory diseases: a 
systematic review, meta-analysis, and investigation of modifier variables. 
Am J Public Health. 2017;108(S2):S123–30.
 10. Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. Epidemiological 
time series studies of PM25 and daily mortality and hospital admissions: a 
systematic review and meta-analysis. Thorax. 2014;69(7):660–5.
 11. Manan N, NoorAizuddin A, Hod R. Effect of air pollution and hospital 
admission: a systematic review. Ann Glob Health. 2018;84(4):670–8.
 12. Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy J Br 
Soc Allergy Clin Immunol. 2011;41(8):1059–71.
 13. Moore E, Chatzidiakou L, Kuku M-O, Jones RL, Smeeth L, Beevers S, et al. 
Global associations between air pollutants and chronic obstructive 
pulmonary disease hospitalizations: a systematic review. Ann Am Thorac 
Soc. 2016;13(10):1814–27.
 14. Song Q, Christiani DC, Xiaorong W, Ren J. The global contribution of 
outdoor air pollution to the incidence, prevalence, mortality and hospital 
admission for chronic obstructive pulmonary disease: a systematic review 
and meta-analysis. Int J Environ Res Public Health. 2014;11(11):11822–32.
 15. Schwartz J. PM10 ozone, and hospital admissions for the elderly in min-
neapolis-St. Paul, Minnesota. Arch Environ Health Int J. 1994;49(5):366–74.
 16. Dockery DW, Speizer FE, Stram DO, Ware JH, Spengler JD, Ferris BG. Effects 
of inhalable particles on respiratory health of children. Am Rev Respir Dis. 
1989;139(3):587–94.
 17. Gasser M, Riediker M, Mueller L, Perrenoud A, Blank F, Gehr P, et al. Toxic 
effects of brake wear particles on epithelial lung cells in vitro. Part Fibre 
Toxicol. 2009;6(1):30.
 18. Behndig AF, Mudway IS, Brown JL, Stenfors N, Helleday R, Duggan ST, 
et al. Airway antioxidant and inflammatory responses to diesel exhaust 
exposure in healthy humans. Eur Respir J. 2006;27(2):359–65.
 19. Sumpter C, Chandramohan D. Systematic review and meta-analysis of 
the associations between indoor air pollution and tuberculosis. Trop Med 
Int Health TM IH. 2013;18(1):101–8.
 20. Kolappan C, Subramani R. Association between biomass fuel and pulmo-
nary tuberculosis: a nested case–control study. Thorax. 2009;64(8):705–8.
 21. Kurmi OP, Sadhra CS, Ayres JG, Sadhra SS. Tuberculosis risk from exposure 
to solid fuel smoke: a systematic review and meta-analysis. J Epidemiol 
Community Health. 2014;68(12):1112–8.
 22. Hwang S, Kang S, Lee J-Y, Lee JS, Kim HJ, Han SK, et al. Impact of outdoor 
air pollution on the incidence of tuberculosis in the Seoul metropolitan 
area, South Korea. Korean J Intern Med. 2014;29(2):183–90.
 23. Popovic I, Magalhaes RJS, Ge E, Marks GB, Dong G-H, Wei X, et al. A 
systematic literature review and critical appraisal of epidemiological 
studies on outdoor air pollution and tuberculosis outcomes. Environ Res. 
2019;170:33–45.
 24. Haddaway NR, Macura B, Whaley P, Pullin AS. ROSES RepOrting standards 
for Systematic Evidence Syntheses: pro forma, flow-diagram and descrip-
tive summary of the plan and conduct of environmental systematic 
reviews and systematic maps. Environ Evid. 2018;7(1):7.
 25. Study Quality Assessment Tools-NHLBI, NIH. https ://www.nhlbi .nih.gov/
healt h-pro/guide lines /in-devel op/cardi ovasc ular-risk-reduc tion/tools . 
Accessed 2 Nov 2017.
 26. What is GRADE? – BMJ Best Practice. https ://bestp racti ce.bmj.com/info/
toolk it/learn -ebm/what-is-grade /. Accessed 17 Jan 2020.
 27. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, 
et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies 
of interventions. BMJ. 2016. https ://www.bmj.com/conte nt/355/bmj.
i4919 . Accessed 2 Nov 2020.
 28. Sterne JA, Egger M, Moher D. Addressing reporting biases. in: cochrane 
handbook for systematic reviews of interventions. New York: Wiley; 2008. 
p. 297–333. https ://onlin elibr ary.wiley .com/doi/abs/10.1002/97804 70712 
184.ch10. Accessed 15 Jan 2020.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
